Skip to main content
. 2023 Oct 20;23:348. doi: 10.1186/s12871-023-02310-x

Table 2.

Intraoperative variables

Parameter Control group (N = 53) Education group (N = 51) Difference in means or medians (95% CI) p value
Intraoperative parameter
Anesthetic time (min) 128.3 ± 41.0 127.9 ± 44.6 0.4 (-16.3, 170) 0.966
Propofol (mg) 1000 [840–1360] 1060 [900–1600] − 70 (-220, 80) 0.354
Remifentanil (mg) 0.55 [0.4–0.85] 0.6 [0.5–0.85] 0.0 (-1, 1) > 0.99
Rocuronium (mg) 55 [50–65] 60 [50–70] -5.0 (-10, 0) 0.034
Crystalloid (mL) 400 [350–550] 450 [350–560] 0 (-50, 50) 0.687
Surgical procedure 0.613
    ESS only 14 (26.4%) 9 (17.7%) N/A
    Septoplasty or turbinoplasty 12 (22.6%) 16 (31.4%) N/A
    ESS with either Septoplasty or turbinoplasty 27 (50.9%) 27 (52.9%) N/A
Surgical site (uni/bi) 19 / 34 (35.9% / 64.2%) 17 / 34 (33.3% / 66.7%) N/A 0.788
Nasal packing (uni/bi), n (%)a 13 / 40 (24.5% / 75.5%) 9 / 42 (17.6% / 82.4%) N/A 0.390
Packing materialsb 0.218
  Nasopore 40 (75.5%) 43 (84.3%) N/A
  Beschitin 4 (7.6%) 5 (9.8%)
  Both (Nasopore and Beschitin) 5 (9.4%) 3 (5.9%)
  Others 4 (7.6%) 0 (0%)
Estimate blood loss (mL) 100 [30–200] 50 [20–200] 0 (-20, 50) 0.659
Parameters at emergence

Coughing, n (%)

(none/mild/moderate/severe)

16 / 5 / 6 / 25 (30.8% / 9.6% /11.5% /48.1%) 16 / 4 / 11 / 20 (31.4% / 7.8% / 21.6% / 39.2%) N/A 0.559
Time to emergence (min) 11 [8–13] 11 [8–14] -1 (-2, 1) 0.493
Time to extubation (min) 12 [10–15] 13 [10–16] -1 (-2,1) 0.366
Agitated emergence 14 (26.9%) 10 (19.6%) N/A 0.418
Adverse eventc 0 (0%) 2 (3.8%) N/A 0.238

Values are the mean ± SD, median [IQR], or number (%)

Agitated emergence was defined as RASS ≥ 1

CI confidence interval, ESS endoscopic sinus surgery, IQR interquartile range, RASS Richmond Agitation-Sedation Scale, SD standard deviation

a In some patients, bilateral nasal packing is performed in unilateral ESS or septo-turbinoplasty at the discretion of the surgeon

b Nasopore and Beschitin are both absorbable nasal packing materials. Others consists of minocell (n = 1) or guardcell (n = 3)

c Two adverse events were nasal bleeding at emergence that required brief bleeding control by surgeons